The Ministry of Health has announced that it granted emergency authorization to Sinopharm's Covid-19 vaccine, on the advice of the National Advisory Committee for the Licensing of the Covid-19 vaccine.
The national advisory committee held a meeting on Friday to finalize the assessment of the technical file of the vaccine, which it has been reviewing for weeks on the basis of the scientific and technical data provided by the Chinese laboratory, the ministry said in a statement.
Following the analysis of scientific and technical data on the manufacturing process, the nature of laboratory analysis of the raw material and the vaccine itself, as well as pre-clinical data and clinical studies results, the National Advisory Committee concluded that the Sinopharm vaccine complies with international standards and WHO recommendations.
"Therefore, this vaccine meets all requirements for quality, efficiency and safety, and causes no potential side effects," the statement said.
This decision paves the way for China's "Sinopharm" laboratory to be granted a 12-month emergency license.